{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:36:58Z","timestamp":1775025418181,"version":"3.50.1"},"reference-count":116,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/bor.0b013e32835d0ee4","type":"journal-article","created":{"date-parts":[[2012,12,29]],"date-time":"2012-12-29T00:34:57Z","timestamp":1356741297000},"page":"260-267","source":"Crossref","is-referenced-by-count":19,"title":["The effect of autoimmune arthritis treatment strategies on regulatory T-cell dynamics"],"prefix":"10.1097","volume":"25","author":[{"given":"Gerdien","family":"Mijnheer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berent J.","family":"Prakken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Femke","family":"van Wijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-18-20210128","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1172\/JCI25112","article-title":"Defective regulatory and effector T cell functions in patients with FOXP3 mutations.","volume":"116","author":"Bacchetta","year":"2006","journal-title":"J Clin Invest"},{"key":"R2-18-20210128","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkheadwinged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse.","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat Genet"},{"key":"R3-18-20210128","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI28880","article-title":"IPEX and the role of Foxp3 in the development and function of human Tregs.","volume":"116","author":"Le Bras","year":"2006","journal-title":"J Clin Invest"},{"key":"R4-18-20210128","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis.","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"R5-18-20210128","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","article-title":"Juvenile idiopathic arthritis.","volume":"377","author":"Prakken","year":"2011","journal-title":"Lancet"},{"key":"R6-18-20210128","first-page":"252","article-title":"Safety of anti-TNFalpha therapy in children with juvenile idiopathic arthritis.","volume":"22","author":"Dekker","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R7-18-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy.","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J Exp Med"},{"key":"R8-18-20210128","doi-asserted-by":"crossref","first-page":"19396","DOI":"10.1073\/pnas.0806855105","article-title":"Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis.","volume":"105","author":"Flores-Borja","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-18-20210128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2005-11-4567","article-title":"TNF downmodulates the function of human CD4CD25hi T-regulatory cells.","volume":"108","author":"Valencia","year":"2006","journal-title":"Blood"},{"key":"R10-18-20210128","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/rheumatology\/kel089","article-title":"Early rheumatoid arthritis is associated with a deficit in the CD4CD25 high regulatory T cell population in peripheral blood.","volume":"45","author":"Lawson","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R11-18-20210128","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/art.20499","article-title":"CD4()CD25() regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid.","volume":"50","author":"van Amelsfort","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R12-18-20210128","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1084\/jem.20050085","article-title":"Coexpression of CD25 and CD27 identifies FoxP3 regulatory T cells in inflamed synovia.","volume":"201","author":"Ruprecht","year":"2005","journal-title":"J Exp Med"},{"key":"R13-18-20210128","doi-asserted-by":"crossref","first-page":"R335","DOI":"10.1186\/ar1192","article-title":"CD25brightCD4 regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease.","volume":"6","author":"Cao","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"R14-18-20210128","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.4049\/jimmunol.172.10.6435","article-title":"CD4CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis.","volume":"172","author":"de Kleer","year":"2004","journal-title":"J Immunol"},{"key":"R15-18-20210128","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1002\/art.30503","article-title":"Impaired suppression of synovial fluid CD4CD25 T cells from patients with juvenile idiopathic arthritis by CD4CD25 Treg cells.","volume":"63","author":"Haufe","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R16-18-20210128","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/art.23291","article-title":"Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers.","volume":"58","author":"Nistala","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R17-18-20210128","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3899\/jrheum.090066","article-title":"Th17 transcription factor RORC2 is inversely correlated with FOXP3 expression in the joints of children with juvenile idiopathic arthritis.","volume":"36","author":"Olivito","year":"2009","journal-title":"J Rheumatol"},{"key":"R18-18-20210128","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood-2010-12-328187","article-title":"Functional human regulatory T cells fail to control autoimmune inflammation due to PKBc-akt hyperactivation in effector cells.","volume":"118","author":"Wehrens","year":"2011","journal-title":"Blood"},{"key":"R19-18-20210128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2249.2005.02754.x","article-title":"CD4 CD25 T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis.","volume":"140","author":"Mottonen","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"R20-18-20210128","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4049\/jimmunol.1000960","article-title":"Profiling of CD4 T cells with epigenetic immune lineage analysis.","volume":"186","author":"Janson","year":"2011","journal-title":"J Immunol"},{"key":"R21-18-20210128","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis.","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"R22-18-20210128","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1126\/science.1078231","article-title":"Toll pathway-dependent blockade of CD4CD25 T cell-mediated suppression by dendritic cells.","volume":"299","author":"Pasare","year":"2003","journal-title":"Science"},{"key":"R23-18-20210128","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/art.22414","article-title":"Proinflammatory mediator-induced reversal of CD4,CD25 regulatory T cell-mediated suppression in rheumatoid arthritis.","volume":"56","author":"van Amelsfort","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R24-18-20210128","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/ard.2007.077669","article-title":"Distribution and clinical significance of blood dendritic cells in children with juvenile idiopathic arthritis.","volume":"67","author":"Smolewska","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R26-18-20210128","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F","article-title":"Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis.","volume":"43","author":"Woo","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R27-18-20210128","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","article-title":"Methotrexate in resistant juvenile rheumatoid arthritis: results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Childrens Study Group.","volume":"326","author":"Giannini","year":"1992","journal-title":"N Engl J Med"},{"key":"R28-18-20210128","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/art.20288","article-title":"A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.","volume":"50","author":"Ruperto","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R30-18-20210128","first-page":"175","article-title":"Methotrexate: how does it really work Nat Rev R","volume":"6","author":"Chan","year":"2010","journal-title":"heumatol"},{"key":"R31-18-20210128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1172\/JCI1554","article-title":"Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5-nucleotidase-mediated conversion of adenine nucleotides.","volume":"101","author":"Morabito","year":"1998","journal-title":"J Clin Invest"},{"key":"R32-18-20210128","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1172\/JCI116884","article-title":"The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.","volume":"92","author":"Cronstein","year":"1993","journal-title":"J Clin Invest"},{"key":"R33-18-20210128","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.22643","article-title":"The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5-nucleotidase: findings in a study of ecto-5-nucleotidase gene-deficient mice.","volume":"56","author":"Montesinos","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R34-18-20210128","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2011-07-366781","article-title":"Alterations in the adenosine metabolism and CD39CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID.","volume":"119","author":"Sauer","year":"2012","journal-title":"Blood"},{"key":"R35-18-20210128","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1074\/jbc.M109.047423","article-title":"Generation and accumulation of immunosuppressive adenosine by human CD4CD25highFOXP3 regulatory T cells.","volume":"285","author":"Mandapathil","year":"2010","journal-title":"J Biol Chem"},{"key":"R36-18-20210128","doi-asserted-by":"crossref","first-page":"6780","DOI":"10.4049\/jimmunol.177.10.6780","article-title":"T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5-adenosine monophosphate to adenosine.","volume":"177","author":"Kobie","year":"2006","journal-title":"J Immunol"},{"key":"R37-18-20210128","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","article-title":"Expression of ectonucleotidase CD39 by Foxp3 Treg cells: hydrolysis of extracellular ATP and immune suppression.","volume":"110","author":"Borsellino","year":"2007","journal-title":"Blood"},{"key":"R38-18-20210128","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.","volume":"204","author":"Deaglio","year":"2007","journal-title":"J Exp Med"},{"key":"R39-18-20210128","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage.","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature"},{"key":"R40-18-20210128","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fimmu.2012.00190","article-title":"The development and immunosuppressive functions of CD4() CD25() FoxP3() regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway.","volume":"3","author":"Ohta","year":"2012","journal-title":"Front Immunol"},{"key":"R41-18-20210128","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review.","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacol Ther"},{"issue":"Suppl 5","key":"R42-18-20210128","doi-asserted-by":"crossref","first-page":"v31","DOI":"10.1093\/rheumatology\/kes116","article-title":"Biologic monotherapy as initial treatment in patients with early rheumatoid arthritis.","volume":"51","author":"Gomez-Reino","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 5","key":"R43-18-20210128","doi-asserted-by":"crossref","first-page":"v12","DOI":"10.1093\/rheumatology\/kes111","article-title":"Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying antirheumatic drugs.","volume":"51","author":"Pavelka","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R44-18-20210128","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.4049\/jimmunol.179.6.4239","article-title":"Interaction between transmembrane TNF and TNFR12 mediates the activation of monocytes by contact with T cells.","volume":"179","author":"Rossol","year":"2007","journal-title":"J Immunol"},{"key":"R45-18-20210128","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/rheumatology\/keq031","article-title":"Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents.","volume":"49","author":"Horiuchi","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R46-18-20210128","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrd3030","article-title":"TNF receptor 2 pathway: drug target for autoimmune diseases.","volume":"9","author":"Faustman","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"R47-18-20210128","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","article-title":"Role of cytokines in rheumatoid arthritis.","volume":"14","author":"Feldmann","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"R48-18-20210128","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1126\/science.1186068","article-title":"Protein kinase C-theta mediates negative feedback on regulatory T cell function.","volume":"328","author":"Zanin-Zhorov","year":"2010","journal-title":"Science"},{"key":"R49-18-20210128","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/eji.201041004","article-title":"The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function.","volume":"41","author":"Herrath","year":"2011","journal-title":"Eur J Immunol"},{"key":"R50-18-20210128","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4049\/jimmunol.179.1.154","article-title":"Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4CD25 T regulatory cells.","volume":"179","author":"Chen","year":"2007","journal-title":"J Immunol"},{"key":"R51-18-20210128","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1172\/JCI42945","article-title":"Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.","volume":"120","author":"Grinberg-Bleyer","year":"2010","journal-title":"J Clin Invest"},{"key":"R52-18-20210128","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/eji.201041205","article-title":"TNF optimally activates regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40.","volume":"41","author":"Hamano","year":"2011","journal-title":"Eur J Immunol"},{"key":"R53-18-20210128","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.4049\/jimmunol.1003868","article-title":"Natural but not inducible regulatory T cells require TNF-alpha signaling for in vivo function.","volume":"186","author":"Housley","year":"2011","journal-title":"J Immunol"},{"key":"R54-18-20210128","first-page":"4190","article-title":"Can TNF-alpha boost regulatory T cells J Clin I","volume":"120","author":"Bilate","year":"2010","journal-title":"nvest"},{"key":"R55-18-20210128","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.4049\/jimmunol.173.12.7259","article-title":"CD25- T cells generate CD25Foxp3 regulatory T cells by peripheral expansion.","volume":"173","author":"Curotto de Lafaille","year":"2004","journal-title":"J Immunol"},{"key":"R56-18-20210128","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20020190","article-title":"Interleukin 2 signaling is required for CD4() regulatory T cell function.","volume":"196","author":"Furtado","year":"2002","journal-title":"J Exp Med"},{"key":"R57-18-20210128","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1073\/pnas.1110120109","article-title":"Scaffold protein Disc large homolog 1 is required for T-cell receptor-induced activation of regulatory T-cell function.","volume":"109","author":"Zanin-Zhorov","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R58-18-20210128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4049\/jimmunol.178.1.201","article-title":"alpha1beta1 Integrin and regulatory Foxp3 T cells constitute two functionally distinct human CD4 T cell subsets oppositely modulated by TNFalpha blockade.","volume":"178","author":"Goldstein","year":"2007","journal-title":"J Immunol"},{"key":"R59-18-20210128","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.4049\/jimmunol.0902070","article-title":"TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function.","volume":"184","author":"Nagar","year":"2010","journal-title":"J Immunol"},{"key":"R60-18-20210128","first-page":"119","article-title":"TNFalpha: activator or inhibitor of regulatory T cells Joint Bone S","volume":"79","author":"Biton","year":"2012","journal-title":"pine"},{"key":"R61-18-20210128","doi-asserted-by":"crossref","first-page":"e30275","DOI":"10.1371\/journal.pone.0030275","article-title":"Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis.","volume":"7","author":"Aaltonen","year":"2012","journal-title":"PLoS One"},{"key":"R62-18-20210128","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.20061531","article-title":"Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta.","volume":"204","author":"Nadkarni","year":"2007","journal-title":"J Exp Med"},{"key":"R63-18-20210128","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/gut.2010.217117","article-title":"Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFalpha treatment.","volume":"60","author":"Veltkamp","year":"2011","journal-title":"Gut"},{"key":"R64-18-20210128","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1167\/iovs.10-5916","article-title":"Induction of regulatory T cells by infliximab in Behcets disease.","volume":"52","author":"Sugita","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R65-18-20210128","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ibd.21308","article-title":"Therapy with anti-TNFalpha antibody enhances number and function of Foxp3() regulatory T cells in inflammatory bowel diseases.","volume":"17","author":"Boschetti","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R66-18-20210128","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2249.2005.02859.x","article-title":"Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis.","volume":"141","author":"Vigna-Perez","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"R67-18-20210128","first-page":"31","article-title":"Influence of antitumor necrosis factor therapy (Adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis.","volume":"24","author":"Dombrecht","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"R68-18-20210128","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/art.23460","article-title":"Suppressor activity among CD4,CD25 T cells is discriminated by membrane-bound tumor necrosis factor alpha.","volume":"58","author":"Wang","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R69-18-20210128","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/rheumatology\/ker183","article-title":"Number and phenotype of rheumatoid arthritis patients CD4CD25hi regulatory T cells are not affected by adalimumab or etanercept.","volume":"50","author":"Blache","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R70-18-20210128","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.imbio.2011.07.006","article-title":"Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and expands IFN-gamma-producing NK cell and regulatory T cell subsets.","volume":"216","author":"Aravena","year":"2011","journal-title":"Immunobiology"},{"key":"R71-18-20210128","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1002\/art.34565","article-title":"Th17 cells are restrained by regulatory T cells from patients responding to anti-TNF antibody therapy via inhibition of IL-6.","volume":"64","author":"McGovern","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R72-18-20210128","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10875-011-9542-6","article-title":"Combined treatment of etanercept and MTX reverses Th1Th2, Th17Treg imbalance in patients with rheumatoid arthritis.","volume":"31","author":"Lina","year":"2011","journal-title":"J Clin Immunol"},{"key":"R73-18-20210128","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00011-012-0520-0","article-title":"Combined use of etanercept and MTX restores CD4()CD8 () ratio and Tregs in spleen and thymus in collagen-induced arthritis.","volume":"61","author":"Huang","year":"2012","journal-title":"Inflamm Res"},{"key":"R74-18-20210128","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature07021","article-title":"IL-21 and TGF-beta are required for differentiation of human T(H)17 cells.","volume":"454","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"R75-18-20210128","doi-asserted-by":"crossref","first-page":"18460","DOI":"10.1073\/pnas.0809850105","article-title":"IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3 regulatory T cells.","volume":"105","author":"Korn","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R76-18-20210128","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/art.22733","article-title":"Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified.","volume":"56","author":"Miossec","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R77-18-20210128","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.clinthera.2012.02.014","article-title":"Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor.","volume":"34","author":"Navarro-Millan","year":"2012","journal-title":"Clin Ther"},{"key":"R78-18-20210128","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"key":"R79-18-20210128","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.yexcr.2011.02.017","article-title":"Inhibition of IL6 in rheumatoid arthritis and juvenile idiopathic arthritis.","volume":"317","author":"Mircic","year":"2011","journal-title":"Exp Cell Res"},{"key":"R80-18-20210128","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.34477","article-title":"Inhibition of IL-6 function corrects Th17Treg imbalance in rheumatoid arthritis patients.","volume":"64","author":"Samson","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R81-18-20210128","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4049\/jimmunol.182.1.259","article-title":"Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation.","volume":"182","author":"Lal","year":"2009","journal-title":"J Immunol"},{"key":"R82-18-20210128","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/annrheumdis-2011-200395","article-title":"Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction.","volume":"71","author":"Smolen","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R83-18-20210128","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ni.1613","article-title":"A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses.","volume":"9","author":"Volpe","year":"2008","journal-title":"Nat Immunol"},{"key":"R84-18-20210128","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","article-title":"Critical regulation of early Th17 cell differentiation by interleukin-1 signaling.","volume":"30","author":"Chung","year":"2009","journal-title":"Immunity"},{"key":"R85-18-20210128","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"key":"R86-18-20210128","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2010.134254","article-title":"A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial).","volume":"70","author":"Quartier","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R87-18-20210128","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/art.10870","article-title":"Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: a large, international, multicenter, placebo-controlled trial.","volume":"48","author":"Fleischmann","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R88-18-20210128","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.molimm.2011.08.020","article-title":"Regulatory immune responses induced by IL-1 receptor antagonist in rheumatoid arthritis.","volume":"49","author":"Niu","year":"2011","journal-title":"Mol Immunol"},{"key":"R89-18-20210128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3 regulatory T cell function.","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"R90-18-20210128","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.0105-2896.2006.00419.x","article-title":"The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology.","volume":"212","author":"Sansom","year":"2006","journal-title":"Immunol Rev"},{"key":"R91-18-20210128","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","article-title":"Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.","volume":"423","author":"Ueda","year":"2003","journal-title":"Nature"},{"key":"R92-18-20210128","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1517\/14712598.2011.592825","article-title":"Abatacept: a biologic immune modulator for rheumatoid arthritis.","volume":"11","author":"Papagoras","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"R93-18-20210128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.immuni.2006.03.001","article-title":"CTLA4Ig: bridging the basic immunology with clinical application.","volume":"24","author":"Bluestone","year":"2006","journal-title":"Immunity"},{"key":"R94-18-20210128","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/intimm\/dxn007","article-title":"CTLA-4 x Ig converts naive CD4CD25- T cells into CD4CD25 regulatory T cells.","volume":"20","author":"Razmara","year":"2008","journal-title":"Int Immunol"},{"key":"R95-18-20210128","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jaut.2009.07.006","article-title":"CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4CD25Foxp3 regulatory T cell population.","volume":"34","author":"Ko","year":"2010","journal-title":"J Autoimmun"},{"key":"R96-18-20210128","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/ni846","article-title":"CTLA-4-Ig regulates tryptophan catabolism in vivo.","volume":"3","author":"Grohmann","year":"2002","journal-title":"Nat Immunol"},{"key":"R97-18-20210128","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/intimm\/dxh140","article-title":"Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.","volume":"16","author":"Mellor","year":"2004","journal-title":"Int Immunol"},{"key":"R98-18-20210128","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","article-title":"The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells.","volume":"176","author":"Fallarino","year":"2006","journal-title":"J Immunol"},{"key":"R99-18-20210128","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","article-title":"B7CD28 costimulation is essential for the homeostasis of the CD4CD25 immunoregulatory T cells that control autoimmune diabetes.","volume":"12","author":"Salomon","year":"2000","journal-title":"Immunity"},{"key":"R100-18-20210128","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.4049\/jimmunol.173.4.2866","article-title":"Targeted CTLA-4 engagement induces CD4CD25CTLA-4high T regulatory cells with target (allo)antigen specificity.","volume":"173","author":"Vasu","year":"2004","journal-title":"J Immunol"},{"key":"R101-18-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jri.2008.11.006","article-title":"CTLA4Ig gene transfer alleviates abortion in mice by expanding CD4CD25 regulatory T cells and inducing indoleamine 2,3-dioxygenase.","volume":"80","author":"Li","year":"2009","journal-title":"J Reprod Immunol"},{"key":"R102-18-20210128","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1600-6143.2011.03929.x","article-title":"Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model.","volume":"12","author":"Riella","year":"2012","journal-title":"Am J Transplant"},{"key":"R103-18-20210128","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1600-6143.2008.02377.x","article-title":"The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation.","volume":"8","author":"Bluestone","year":"2008","journal-title":"Am J Transplant"},{"key":"R104-18-20210128","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.trim.2007.01.005","article-title":"Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD8086 blockade.","volume":"17","author":"Chavez","year":"2007","journal-title":"Transpl Immunol"},{"key":"R105-18-20210128","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s10875-011-9527-5","article-title":"CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis.","volume":"31","author":"Alvarez-Quiroga","year":"2011","journal-title":"J Clin Immunol"},{"key":"R106-18-20210128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1586\/eci.10.96","article-title":"Regulatory T-cell adoptive immunotherapy: potential for treatment of autoimmunity.","volume":"7","author":"Wright","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"R107-18-20210128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fimmu.2012.00165","article-title":"Functional crosstalk between dendritic cells and Foxp3() regulatory T cells in the maintenance of immune tolerance.","volume":"3","author":"Kornete","year":"2012","journal-title":"Front Immunol"},{"key":"R108-18-20210128","first-page":"1632","article-title":"Treating arthritis by immunomodulation: is there a role for regulatory T cells Rheumatology (Oxford","volume":"49","author":"Wehrens","year":"2010","journal-title":")"},{"key":"R109-18-20210128","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaci.2011.10.037","article-title":"Application of cultured human regulatory T cells requires preclinical in vivo evaluation.","volume":"129","author":"Vercoulen","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R110-18-20210128","doi-asserted-by":"crossref","first-page":"16717","DOI":"10.1073\/pnas.1112722108","article-title":"Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxp3 expression in pathogenic synovial T cells.","volume":"108","author":"Beavis","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R111-18-20210128","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2009-02-207118","article-title":"Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization.","volume":"115","author":"van Loosdregt","year":"2010","journal-title":"Blood"},{"key":"R112-18-20210128","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/art.30238","article-title":"Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis.","volume":"63","author":"Vojinovic","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R113-18-20210128","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.it.2011.04.007","article-title":"PKC-theta function at the immunological synapse: prospects for therapeutic targeting.","volume":"32","author":"Zanin-Zhorov","year":"2011","journal-title":"Trends Immunol"},{"key":"R114-18-20210128","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrrheum.2011.36","article-title":"Induction of immune tolerance in the treatment of rheumatoid arthritis.","volume":"7","author":"Albani","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"R115-18-20210128","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nri1593","article-title":"Heat-shock proteins induce T-cell regulation of chronic inflammation.","volume":"5","author":"van Eden","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R116-18-20210128","first-page":"17","article-title":"A new-age for biologic therapies: long-term drug-free therapy with BiP Front I","volume":"3","author":"Shields","year":"2012","journal-title":"mmunol"},{"key":"R117-18-20210128","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fimmu.2012.00178","article-title":"Multiple treg suppressive modules and their adaptability.","volume":"3","author":"Wing","year":"2012","journal-title":"Front Immunol"},{"key":"R118-18-20210128","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1182\/blood-2011-11-392324","article-title":"Functionally distinct subsets of human FOXP3 Treg cells that phenotypically mirror effector Th cells.","volume":"119","author":"Duhen","year":"2012","journal-title":"Blood"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0b013e32835d0ee4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:05:03Z","timestamp":1620947103000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201303000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":116,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e32835d0ee4","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}